InvestorsHub Logo
Followers 7
Posts 496
Boards Moderated 0
Alias Born 11/15/2012

Re: None

Monday, 09/09/2013 3:11:51 PM

Monday, September 09, 2013 3:11:51 PM

Post# of 16750
Quoted from another message board:

"What a kick in the coin purse. MT pretty much killed any hope for the Sept 14th presentation and all hopes that CLSN would have the data to go to the FDA or SFDA for that matter. Announcing another trial starting next year puts CLSN on the shelf for at least 3yrs. The dream is over but is not dead. I just wish I could take a 3yr nap and wake up to a blockbuster stock. With today's presentation we will see sub $1. I hate to admit it but CLSN is no closer than if they never ran a Heat study except they discovered that dwell time improves Thermodox and abalation vs abalation alone. How did they miss that in the first protocol for phase 3. It seems the Dignity trial was a smokescreen to soften the blow for announcing new Heat trial with longer durations. Very sad day for longs like myself that thought CLSN had some meat on the bone for chances of using sub group for approval in China. No mention of HINSUN agreement, nothing positive, we are dead in the water for years. If possible please convince me otherwise.... Not sure how u could."

It's tough to refute the cold facts. Can anyone?